Literature DB >> 3124800

Alteration of monocyte function following major injury.

E Faist1, A Mewes, T Strasser, A Walz, S Alkan, C Baker, W Ertel, G Heberer.   

Abstract

The macrophage exerts its stimulatory and regulatory functions within the specific immune response via the interleukin 1 (IL-1) and prostaglandin E2 (PGE2), respectively. In a screening study of macrophage-related variables following injury, a total of 58 patients (mean age, 32 years; mean injury Severity Score, 38), macrophagic phenotyping with the monoclonal antibody Leu M3 and serial measuring of the antagonistic monokines IL-1 and PGE2 and of the macrophage-activating lymphokine interferon gamma were carried out on posttrauma days 0, 1, 3, 5, 7, 10, 14, and 21. The posttraumatic course was characterized by significant monocytosis, showing a peak value of 32% of Leu M3-positive cells compared with 15% of these cells in normal control subjects. During the posttrauma course, the macrophagic PGE2 output was significantly elevated up to eightfold on days 5 and 7 compared with that of control subjects (0.441 +/- 0.14 ng/mL vs 0.052 +/- 0.01 ng/mL). Conversely, macrophagic IL-1 synthesis was significantly suppressed until day 10. Levels of interferon gamma were suppressed to a significant degree during the two-day observation period, with a trend to slow recovery at the end of week 3. These data suggest that a negative regulatory macrophagic function may be the event initiating posttraumatic immunosuppression. To restore impaired macrophagic T-helper cell interaction, cyclo-oxygenase inhibition and substitution of interferon gamma may be useful to potentiate facilitatory macrophagic function and to block inhibitory macrophagic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124800     DOI: 10.1001/archsurg.1988.01400270021002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  36 in total

1.  Interferon gamma in trauma-related infections.

Authors:  D J Dries
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

2.  Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.

Authors:  J D Ioannovich; R D Hinzmann; G Deichsel; G G Steinmann
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

3.  Comparison of trauma assessment scores and their use in prediction of infection and death.

Authors:  W G Cheadle; M Wilson; M J Hershman; D Bergamini; J D Richardson; H C Polk
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

4.  Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumonia.

Authors:  Patricia A Manderscheid; Ryan P Bodkin; Bruce A Davidson; Erik Jensen; Thomas A Russo; Paul R Knight
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

5.  IL-2 regulation of soluble IL-2 receptor levels following thermal injury.

Authors:  J A Teodorczyk-Injeyan; B G Sparkes; S Lalani; W J Peters; G B Mills
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Role of elevated monocyte transforming growth factor beta (TGF beta) production in posttrauma immunosuppression.

Authors:  C L Miller-Graziano; G Szabo; K Griffey; B Mehta; K Kodys; D Catalano
Journal:  J Clin Immunol       Date:  1991-03       Impact factor: 8.317

7.  Elevated monocyte interleukin-6 (IL-6) production in immunosppressed trauma patients. II. Downregulation by IL-4.

Authors:  G Szabo; K Kodys; C L Miller-Graziano
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

8.  The effect of ranitidine on cellular immunity in patients with multiple myeloma.

Authors:  H J Nielsen; H Nielsen; F Moesgaard; N Tvede; K Klarlund; B Mansa; A Drivsholm
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

9.  Modulation of infection by gamma interferon treatment following trauma.

Authors:  M J Hershman; H C Polk; J D Pietsch; R E Shields; S R Wellhausen; G Sonnenfeld
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Changes in monocytic expression of aminopeptidase N/CD13 after major trauma.

Authors:  G Huschak; K Zur Nieden; R Stuttmann; D Riemann
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.